author-photo

Li-Tzong Chen

National Health Research Institutes
Kaohsiung Medical University
National Cheng Kung University

432

Papers

9500

Citations

Citation Trend

Filter By

Papers (432) Sort By

JournalConferenceOthers

Revisiting the Full Spectrum of Helicobacter pylori-Related Gastric Lymphoma

2021
Show All
- Source
- Cite
- Save
Citations (0)
Nivolumab in previously treated advanced gastric cancer (ATTRACTION-2): 3-year update and outcome of treatment beyond progression with nivolumab.

2021 Gastric Cancer
Show All
- Source
- Cite
- Save
Citations (5)
Development of Possible Next Line of Systemic Therapies for Gemcitabine-Resistant Biliary Tract Cancers: A Perspective from Clinical Trials.

2021
Show All
- Source
- Cite
- Save
Citations (3)
Comparing survival and subsequent treatment of first-line tyrosine kinase inhibitors in patients of advanced lung adenocarcinoma with epidermal growth factor receptor mutation.

2021 Journal of the Formosan Medical Association
Show All
- Source
- Cite
- Save
Citations (1)
The Prognostic and Predictive Role of Chromogranin A in Gastroenteropancreatic Neuroendocrine Tumors – A Single-Center Experience

2021 Frontiers in Oncology
Show All
- Source
- Cite
- Save
Citations (0)
TCOG T5217 trial: A phase II randomized study of SLOG versus modified FOLFIRINOX as the first-line treatment in locally advanced or metastatic pancreatic ductal adenocarcinoma.

2021 Journal of Clinical Oncology
Show All
- Source
- Cite
- Save
Citations (0)
Phase I dose escalation study of sorafenib plus S-1 for advanced solid tumors.

2021 Scientific Reports
Show All
- Source
- Cite
- Save
Citations (0)
CE3 Systematic Review and Indirect Comparison of PD-(L)1 Inhibitors in Combination with Platinum-Based Doublet Chemotherapy (PT-DC) for the First-Line Treatment of Non-Squamous, Non-Small-Cell Lung Cancer (nsqNSCLC)

2021 Value in Health
- Lu Zhang
- Y. Qian
- Jing Li
- C Cui
- Li-Tzong Chen
- S. Qu
- S. Lu
Show All
- Source
- Cite
- Save
Citations (0)
Phase I study of H3B-6527 in hepatocellular carcinoma (HCC) or intrahepatic cholangiocarcinoma (ICC).

2021 Journal of Clinical Oncology
Show All
- Source
- Cite
- Save
Citations (0)
PCN71 Treatment-Related Costs of Pharmacologic Regimens for Patients with Relapsed or Refractory Diffuse Large B-Cell Lymphoma (R/R DLBCL) Who Have Received Two or More Prior Lines of Therapies

2021 Value in Health
- L Liao
- C. Yang
- X. Yang
- Li-Tzong Chen
- Jipan Xie
Show All
- Source
- Cite
- Save
Citations (0)

© Copyright 2015-2020 Acemap, Inc. Shanghai Jiao Tong University.

沪ICP备18028330号